Elsevier

Biochemical Pharmacology

Volume 37, Issue 6, 15 March 1988, Pages 1111-1116
Biochemical Pharmacology

Alterations in pulmonary protective enzymes following systemic bleomycin treatment in mice

https://doi.org/10.1016/0006-2952(88)90518-7Get rights and content

Abstract

Repeated bleomycin administration in animals and humans produces significant lung fibrosis. The pathogenesis of this toxicity may be multifactorial, but it appears to be initiated through the production of radical oxygen species by an activated bleomycin-iron-oxygen ternary complex. Protection of lung tissue from bleomycin-induced toxicity may occur through both specific metabolic inactivation of bleomycin by the enzyme bleomycin hydrolase, as well as by such non-specific antioxidants as catalase and the glutathione system. The effect of chronic, systemic administration of bleomycin on the activities and levels of these enzymes and proteins in pulmonary tissue is unknown. C57BL/6 mice were injected subcutaneously with saline, non-fibrogenic (2mg/kg) and fibrogenic (10mg/kg) doses of bleomycin twice-weekly for 6 weeks. Animals were killed at 0, 1.5, 3, and 6 weeks after initiation of bleomycin treatment. Catalase activity was increased more than 50% at 3 weeks in the low-dose animals, and was decreased over 40% at 6 weeks in the high-dose animals. Total lung glutathione levels were unaffected in both groups, although glutathione reductase activity was increased significantly (over 2-fold) at 1.5 and 3 weeks in the high-dose animals. At 6 weeks glutathione reductase was increased 7- and 12-fold in low and high-dose animals respectively. Glutathione peroxidase activity also was elevated more than 2-fold above control values at 6 weeks in both sets of animals. There was no evidence of induction of bleomycin hydrolase activity at any time point. Rather, bleomycin hydrolase activity was decreased significantly to 30 and 40% of control values at 3 and 6 weeks, respectively, in mice receiving the fibrogenic doses of bleomycin. These results demonstrate that chronic, systemic administration of non-fibrogenic and fibrogenic doses of bleomycin produces changes in activity of lung antioxidant defense mechanisms. The early loss of lung bleomycin hydrolase activity may contribute to the pathogenesis of bleomycin-induced pulmonary toxicity following repeated drug exposure.

References (30)

  • B.I. Sikic
  • F.M. Muggia et al.

    Cancer Treat. Rev.

    (1983)
  • S.N. Giri et al.

    Toxic. appl. Pharmac.

    (1983)
  • R.C. Lindenschmidt et al.

    Toxic. appl. Pharmac.

    (1986)
  • J.P. Kehrer et al.

    Toxic. Lett.

    (1986)
  • J.S. Lazo

    Toxic. appl. Pharmac.

    (1981)
  • F. Vyskocil et al.

    Biochem. biophys. Res. Commun.

    (1983)
  • G. Fitzgerald et al.

    Biochem. biophys. Res. Commun.

    (1981)
  • M.M. Bradford

    Analyt. Biochem.

    (1976)
  • R.N. Feinstein

    J. biol. Chem.

    (1949)
  • O.W. Griffith

    Analyt. Biochem.

    (1980)
  • J.M. Patel et al.

    Toxic. appl. Pharmac.

    (1984)
  • A. Russo et al.

    Int. J. Radiat. Oncol. Biol. Phys.

    (1984)
  • J.C. Dabrowiak

    J. inorg. Chem.

    (1980)
  • H. Umezawa et al.

    J. Antibiot. Tokyo

    (1974)
  • Cited by (49)

    • Epicatechin protective effects on bleomycin-induced pulmonary oxidative stress and fibrosis in mice

      2019, Biomedicine and Pharmacotherapy
      Citation Excerpt :

      The oxidative stress that activates inflammatory signaling pathways causes oxidative damage [45]. In BLM model of lung injury, oxidative damage is a condition due to the lack of balance between ROS production and the antioxidant defense system [46,47]. It has been reported that oxidative stress and inflammation are early and fibrosis is a late event in BLM model of lung damage [12,15].

    • Oxidative toxicology of bleomycin: Role of the extracellular redox environment

      2019, Current Opinion in Toxicology
      Citation Excerpt :

      The pyrimidine and imidazole moieties that bind oxygen and iron result in the formation of free radical species such as O2−, hydroxyl radicals and Fe (III). The bleomycin complex then binds to DNA helix through a bithiazol ring, resulting in DNA strand breaks and lipid peroxidation [9,10]. The result is an increase in cellular injury, which is then followed by an inflammatory response.

    • Celastrol enhances Nrf2 mediated antioxidant enzymes and exhibits anti-fibrotic effect through regulation of collagen production against bleomycin-induced pulmonary fibrosis

      2016, Chemico-Biological Interactions
      Citation Excerpt :

      During oxidative stress, rapid over-production of free radicals overwhelms the detoxification and scavenging capacity of cellular anti-oxidant enzymes like SOD, CAT, GPx, GR and non-enzymatic antioxidants such as vitamin E, vitamin C and GSH, resulting in a severe damage to macromolecules and generate toxic lipid peroxides that ultimately leads to organ failure [11]. BLM administration in animals results in increased lipid peroxidation (LPO) and alters the activities of antioxidant enzymes in BALF and lung tissue has been documented [42]. Plant secondary metabolites act as powerful antioxidants providing a remarkable protection against oxidative and free radical damage.

    • Protective effect of gallic acid against bleomycin-induced pulmonary fibrosis in rats

      2015, Pharmacological Reports
      Citation Excerpt :

      Also, several studies suggested a similar relation in humans as well [10,12]. The lung is selectively influenced because this tissue lacks an enzyme that hydrolyzes the bleomycin, which prevents its metabolite from binding to metal ions and DNA [13]. The complex metabolites can generate ROS such as superoxide and hydroxyl radicals [11].

    View all citing articles on Scopus

    Supported by National Institutes of Health Grants (CA-01012; CA-25883), American Cancer Society Grant CH-316, and a grant from the Parker B. Francis Foundation.

    Current address: Department of Pharmacology, 518 Scaife Hall, University of Pittsburgh, School of Medicine, Pittsburgh, PA 15261.

    View full text